David S. Kaplan

3.3k total citations
79 papers, 2.0k citations indexed

About

David S. Kaplan is a scholar working on Rheumatology, Economics and Econometrics and Gastroenterology. According to data from OpenAlex, David S. Kaplan has authored 79 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Rheumatology, 17 papers in Economics and Econometrics and 10 papers in Gastroenterology. Recurrent topics in David S. Kaplan's work include Systemic Lupus Erythematosus Research (15 papers), Gastrointestinal motility and disorders (10 papers) and Labor market dynamics and wage inequality (8 papers). David S. Kaplan is often cited by papers focused on Systemic Lupus Erythematosus Research (15 papers), Gastrointestinal motility and disorders (10 papers) and Labor market dynamics and wage inequality (8 papers). David S. Kaplan collaborates with scholars based in United States, Mexico and Sweden. David S. Kaplan's co-authors include Herbert S. Diamond, Ellen M. Ginzler, Eduardo Piedra, Enrique Seira, Prakash S. Masand, Michael Schlesinger, Sanjay Gupta, Max Weiner, Sanjay Gupta and Mitchel J. Seleznick and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

David S. Kaplan

73 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David S. Kaplan United States	27	469	329	264	195	193	79	2.0k
Anne Lee United States	26	118 0.3×	116 0.4×	145 0.5×	62 0.3×	500 2.6×	103	3.3k
Jeffrey D. Lewis United States	22	99 0.2×	568 1.7×	39 0.1×	68 0.3×	118 0.6×	77	2.7k
John Lambert Australia	34	342 0.7×	26 0.1×	510 1.9×	127 0.7×	1.4k 7.2×	147	3.4k
Richard S. Panush United States	29	1.1k 2.3×	24 0.1×	44 0.2×	234 1.2×	593 3.1×	153	2.6k
Eleni Linos United States	31	108 0.2×	83 0.3×	27 0.1×	308 1.6×	223 1.2×	96	4.0k
Daniel Feldman Brazil	17	588 1.3×	38 0.1×	18 0.1×	101 0.5×	80 0.4×	60	1.8k
Massimo Amato Italy	29	47 0.1×	63 0.2×	97 0.4×	87 0.4×	247 1.3×	192	2.5k
Ghazala Khan United Kingdom	9	715 1.5×	370 1.1×	16 0.1×	405 2.1×	321 1.7×	22	4.7k
Gareth Williams United Kingdom	24	32 0.1×	86 0.3×	63 0.2×	182 0.9×	331 1.7×	50	1.4k
Vera H. Price United States	37	276 0.6×	107 0.3×	14 0.1×	772 4.0×	230 1.2×	88	5.4k

Countries citing papers authored by David S. Kaplan

Since Specialization

Citations

This map shows the geographic impact of David S. Kaplan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Kaplan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Kaplan more than expected).

Fields of papers citing papers by David S. Kaplan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Kaplan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Kaplan. The network helps show where David S. Kaplan may publish in the future.

Co-authorship network of co-authors of David S. Kaplan

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Kaplan. A scholar is included among the top collaborators of David S. Kaplan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Kaplan. David S. Kaplan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bauer, Steven R., et al.. (2018). FDA and NIST collaboration on standards development activities supporting innovation and translation of regenerative medicine products. Cytotherapy. 20(6). 779–784. 18 indexed citations

Kaplan, David S., et al.. (2016). Separation of Mesenchymal Stem Cells Through a Strategic Centrifugation Protocol. Tissue Engineering Part C Methods. 22(4). 348–359. 2 indexed citations

Prendergast, Margaret E., et al.. (2016). Influence of 3D printed porous architecture on mesenchymal stem cell enrichment and differentiation. Acta Biomaterialia. 32. 161–169. 88 indexed citations

Bosch, Mariano, et al.. (2015). Jobs for Growth. 3 indexed citations

Kaplan, David S., et al.. (2014). Shelter-in-place and mental health: An analogue study of well-being and distress. Journal of Emergency Management. 12(2). 121–131. 11 indexed citations

Kaplan, David S., et al.. (2012). Centrifugation Assay for Measuring Adhesion of Serially Passaged Bovine Chondrocytes to Polystyrene Surfaces. Tissue Engineering Part C Methods. 18(7). 537–544. 5 indexed citations

McCright, Brent, Jiyoung M. Dang, Deborah A. Hursh, et al.. (2009). Synopsis of the Food and Drug Administration–National Institute of Standards and Technology Co-Sponsored “ In Vitro Analyses of Cell/Scaffold Products” Workshop. Tissue Engineering Part A. 15(3). 455–460. 5 indexed citations

Lee, Kyongbum, David S. Kaplan, & Jason P. Acker. (2007). Basics of tissue engineering and tissue applications. Springer eBooks. 2 indexed citations

Seira, Enrique, David S. Kaplan, & Eduardo Piedra. (2006). Are Burdensome Registration Procedures an Important Barrier on Firm Creation? Evidence from Mexico. SSRN Electronic Journal. 15 indexed citations

10.

Masand, Prakash S., Sanjay Gupta, Thomas L. Schwartz, et al.. (2005). Open-Label Treatment With Citalopram in Patients With Irritable Bowel Syndrome. The Primary Care Companion For CNS Disorders. 7(4). 162–6. 19 indexed citations

11.

Garakani, Amir, et al.. (2003). Comorbidity of Irritable Bowel Syndrome in Psychiatric Patients: A Review. American Journal of Therapeutics. 10(1). 61–67. 112 indexed citations

12.

Masand, Prakash S., Sanjay Gupta, Thomas L. Schwartz, et al.. (2002). Paroxetine in Patients With Irritable Bowel Syndrome. The Primary Care Companion For CNS Disorders. 4(1). 12–16. 25 indexed citations

13.

Masand, Prakash S., Sanjay Gupta, Thomas L. Schwartz, et al.. (2002). Does a Preexisting Anxiety Disorder Predict Response to Paroxetine in Irritable Bowel Syndrome?. Psychosomatics. 43(6). 451–455. 17 indexed citations

14.

Pursnani, Kishore, Lelan F. Sillin, & David S. Kaplan. (1997). Effect of transjugular intrahepatic portosystemic shunt on secondary hypersplenism. The American Journal of Surgery. 173(3). 169–173. 28 indexed citations

15.

Kaplan, David S., Prakash Masand, & Sanjay Gupta. (1996). The Relationship of Irritable Bowel Syndrome (IBS) and Panic Disorder1. Annals of Clinical Psychiatry. 8(2). 81–88. 52 indexed citations

16.

Kaplan, David S., E Ginzler, & Joseph Feldman. (1992). Arthritis and hypertension in patients with systemic lupus erythematosus. Arthritis & Rheumatism. 35(4). 423–428. 3 indexed citations

17.

Kaplan, David S., et al.. (1992). Asymmetric clubbing as a manifestation of sarcoid bone disease. The American Journal of Medicine. 93(4). 471–471. 2 indexed citations

18.

Kaplan, David S. & Joseph Feldman. (1991). A Preliminary Study of Excess Risk of Cardiovascular Disease in the Mothers of Patients with Rheumatoid Arthritis. American Journal of Epidemiology. 133(7). 715–720. 2 indexed citations

19.

Kaplan, David S., Uma K. Murthy, & Willem G. Linscheer. (1989). Percutaneous endoscopic jejunostomy: long-term follow-up of 23 patients. Gastrointestinal Endoscopy. 35(5). 403–406. 64 indexed citations

20.

Mitchell, J. & David S. Kaplan. (1956). Granular-cell myoblastoma of the labium majus. American Journal of Obstetrics and Gynecology. 71(4). 901–903. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact